Abbott Laboratories (ABT) vs Novo Nordisk A/S (NVO)
A side-by-side comparison of Abbott Laboratories and Novo Nordisk A/S across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.
ABT
Abbott Laboratories
$105.70HealthcareDelayed quote: Jul 31, 2026, 4:02 PM EDT
NVO
Novo Nordisk A/S
$47.08HealthcareDelayed quote: Jul 31, 2026, 3:59 PM EDT
Total return — ABT vs NVO
growth of $100 · dividends reinvested · last 30yABT +1948.2%NVO +10806.6%NVO compounded faster
Log scale — wide-divergence pair
ABT NVO
ABT vs NVO: by the numbers
- •NVO is the larger company ($209.19B vs $184.11B market cap).
- •NVO trades at the lower trailing earnings multiple (11.01 vs 33.96 P/E), one valuation lens rather than an overall verdict.
- •NVO converts more revenue to profit (37.14% vs 11.65% net margin).
- •NVO grew revenue faster over the past five years (20.73% vs 2.98% CAGR).
- •NVO pays the higher dividend yield (3.83% vs 2.31%).
Metrics side by side
Valuation
| Metric | ABT | NVO |
|---|---|---|
| P/E ratio | 33.96 | 11.01 |
| Forward P/E | 19.15 | N/A |
| P/S ratio | 3.95 | 4.09 |
| P/B ratio | 3.54 | 6.69 |
| PEG ratio | 4.13 | 8.16 |
| EV / EBITDA | 21.37 | 8.62 |
| FCF yield | 4.00% | 2.31% |
Profitability
| Metric | ABT | NVO |
|---|---|---|
| Gross margin | 56.80% | 81.83% |
| Operating margin | 17.03% | 45.21% |
| Net margin | 11.65% | 37.14% |
| ROE | 10.42% | 60.74% |
| ROIC | 8.43% | 29.53% |
Dividends
| Metric | ABT | NVO |
|---|---|---|
| Dividend yield | 2.31% | 3.83% |
| Payout ratio | 65.24% | 49.80% |
Growth (annualized)
| Metric | ABT | NVO |
|---|---|---|
| Revenue CAGR (5Y) | 2.98% | 20.73% |
| EPS CAGR (5Y) | 8.22% | 19.59% |
| FCF CAGR (5Y) | 5.26% | -5.86% |
| Total return CAGR (5Y) | -0.78% | 2.46% |
Frequently asked
- Which has the lower trailing P/E, ABT or NVO?
- NVO has the lower trailing P/E: ABT trades at 33.96 and NVO at 11.01. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABT or NVO?
- Over the past five years, NVO grew revenue faster — ABT at a 2.98% CAGR versus NVO at 20.73%.
- Does ABT or NVO pay a bigger dividend?
- ABT yields 2.31% and NVO yields 3.83% based on trailing dividends and the latest price.
- Is ABT or NVO more profitable?
- NVO runs the higher net margin — ABT at 11.65% versus NVO at 37.14%.
- How have ABT and NVO total returns compared?
- Over the past 10 years, ABT delivered 11.02% and NVO delivered 7.59% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Abbott Laboratories P/E ratioNovo Nordisk A/S P/E ratioAbbott Laboratories dividend yieldNovo Nordisk A/S dividend yieldAbbott Laboratories ROENovo Nordisk A/S ROEAbbott Laboratories operating marginNovo Nordisk A/S operating marginAbbott Laboratories revenue growthNovo Nordisk A/S revenue growthAbbott Laboratories free cash flowNovo Nordisk A/S free cash flow
Abbott Laboratories & Novo Nordisk A/S appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.